Mefloquine: the benefits outweigh the risks.
Department of Pharmacology and Therapeutics, University of Liverpool, UK.
P
P
Winstanley
D000962:Antimalarials / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D016778:Malaria, Falciparum / Q000517:prevention & control; D015767:Mefloquine / Q000009:adverse effects / Q000627:therapeutic use*; D012306:Risk
D000962:Antimalarials; D015767:Mefloquine